Medicilon-MPI Preclinical Research (Shanghai) LLC Offers US FDA GLP Services
Published: Dec 08, 2009
SHANGHAI, China--(BUSINESS WIRE)--Medicilon/MPI Preclinical Research-Shanghai has recently expanded their service offerings to provide Sponsors with the ability to conduct studies that meet the US FDA Good Laboratory Practice (GLP) regulations, at their Chuansha facility in Shanghai China.